| __timestamp | Jazz Pharmaceuticals plc | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 406114000 | 5496000 |
| Thursday, January 1, 2015 | 449119000 | 9786000 |
| Friday, January 1, 2016 | 502892000 | 6792000 |
| Sunday, January 1, 2017 | 544156000 | 7313000 |
| Monday, January 1, 2018 | 683530000 | 8382000 |
| Tuesday, January 1, 2019 | 736942000 | 10803000 |
| Wednesday, January 1, 2020 | 854233000 | 12944000 |
| Friday, January 1, 2021 | 1451683000 | 21967000 |
| Saturday, January 1, 2022 | 1416967000 | 32810000 |
| Sunday, January 1, 2023 | 1343105000 | 46542000 |
In pursuit of knowledge
In the competitive world of pharmaceuticals, managing Selling, General, and Administrative (SG&A) expenses is crucial for maintaining profitability. Jazz Pharmaceuticals plc and Xenon Pharmaceuticals Inc. offer a fascinating study in contrasts from 2014 to 2023. Jazz Pharmaceuticals, a major player, saw its SG&A expenses grow by over 230%, peaking in 2021. This reflects their aggressive expansion and marketing strategies. In contrast, Xenon Pharmaceuticals, a smaller entity, experienced a more modest increase of around 750%, albeit from a much smaller base. Their expenses rose steadily, indicating a strategic scaling of operations. By 2023, Jazz's expenses were nearly 29 times higher than Xenon's, highlighting the disparity in their operational scales. This data underscores the diverse strategies employed by pharmaceutical companies in managing their operational costs over the years.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Comparing SG&A Expenses: Bio-Techne Corporation vs Jazz Pharmaceuticals plc Trends and Insights
Cost Management Insights: SG&A Expenses for Jazz Pharmaceuticals plc and Soleno Therapeutics, Inc.
Comparing SG&A Expenses: Jazz Pharmaceuticals plc vs Bausch Health Companies Inc. Trends and Insights
Jazz Pharmaceuticals plc and Ligand Pharmaceuticals Incorporated: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Jazz Pharmaceuticals plc and Amphastar Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc vs Xencor, Inc.: SG&A Expense Trends
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: SG&A Expense Trends
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.